Denali Advisors LLC Has $3.78 Million Position in Select Medical Holdings Co. (NYSE:SEM)

Denali Advisors LLC raised its holdings in Select Medical Holdings Co. (NYSE:SEM) by 96.7% in the first quarter, Holdings Channel.com reports. The fund owned 125,483 shares of the health services provider’s stock after acquiring an additional 61,700 shares during the quarter. Denali Advisors LLC’s holdings in Select Medical were worth $3,783,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Vanguard Group Inc. lifted its stake in shares of Select Medical by 2.9% in the fourth quarter. Vanguard Group Inc. now owns 12,347,798 shares of the health services provider’s stock worth $290,173,000 after buying an additional 342,496 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Select Medical by 1.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,431,681 shares of the health services provider’s stock valued at $104,147,000 after buying an additional 48,300 shares during the period. Victory Capital Management Inc. increased its holdings in Select Medical by 15.7% in the 4th quarter. Victory Capital Management Inc. now owns 1,739,361 shares of the health services provider’s stock valued at $40,875,000 after buying an additional 235,964 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Select Medical by 5.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,467,109 shares of the health services provider’s stock valued at $34,477,000 after buying an additional 79,907 shares during the period. Finally, Norges Bank bought a new stake in Select Medical in the 4th quarter valued at $34,320,000. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Price Performance

NYSE SEM traded up $0.14 on Wednesday, hitting $36.30. 401,538 shares of the company were exchanged, compared to its average volume of 594,507. The firm has a 50 day moving average of $33.02 and a two-hundred day moving average of $29.14. The company has a market cap of $4.72 billion, a P/E ratio of 17.29, a P/E/G ratio of 1.67 and a beta of 1.43. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 2.30. Select Medical Holdings Co. has a 1-year low of $21.28 and a 1-year high of $36.44.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, May 2nd. The health services provider reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.22. Select Medical had a return on equity of 18.11% and a net margin of 3.97%. The company had revenue of $1.79 billion during the quarter, compared to analysts’ expectations of $1.70 billion. On average, equities analysts predict that Select Medical Holdings Co. will post 2.1 EPS for the current year.

Select Medical Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 30th. Investors of record on Thursday, May 16th were paid a dividend of $0.125 per share. The ex-dividend date was Wednesday, May 15th. This represents a $0.50 dividend on an annualized basis and a yield of 1.38%. Select Medical’s payout ratio is 23.81%.

Insider Transactions at Select Medical

In other news, Chairman Robert A. Ortenzio sold 50,000 shares of Select Medical stock in a transaction on Monday, April 8th. The stock was sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the completion of the sale, the chairman now owns 6,689,668 shares of the company’s stock, valued at $200,021,073.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 17.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Royal Bank of Canada boosted their price target on shares of Select Medical from $36.00 to $40.00 and gave the company an “outperform” rating in a report on Monday, May 6th. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, March 22nd. Finally, Benchmark reaffirmed a “buy” rating and issued a $39.00 target price on shares of Select Medical in a report on Friday, May 3rd. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $34.25.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.